ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

<link med fakultaet med-detailseiten news-detail article rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv>www.uni-ulm.de/med/fakultaet/med-detailseiten/news-detail/article/rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv/

Contact Bluesky logoX logoGitHub logo

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89081 Ulm
Germany

Tel: +49 731 50 22911
Fax: +49 731 50 22924

Office: Building M26, room 4117

Click here if you are interested in joining the group.

Most Recent Papers

Quantum Cramér-Rao Precision Limit of Noisy Continuous Sensing, Phys. Rev. Lett. 136, 070802 (2026), arXiv:2504.12400

Resource-state generation for a multispin register in a hybrid matter-photon quantum information processor, Phys. Rev. Applied 25, 024002 (2026), arXiv:2408.17265

Optically Hyperpolarized Materials for Levitated Optomechanics, Quantum 9, 1928 (2025)

Quantum Fisher information from tensor-network integration of the Lyapunov equation, Phys. Rev. A 112, 052454 (2025), arXiv:2506.11330

Physically constrained quantum clock-driven dynamics, New J. Phys. 27, 114501 (2025), arXiv:2409.02857